AG真人官方

Snowflake Inc. (SNOW) Form 4 filing 鈥� 07/03/2025

Director Mark D. McLaughlin reported the award of 1,373 restricted stock units (RSUs) on 07/02/2025 at a cost basis of $0. The RSUs will vest in full on the earlier of (i) Snowflake鈥檚 2026 annual shareholder meeting or (ii) one year from the grant date, subject to continued board service.

After the transaction, McLaughlin鈥檚 beneficial ownership stands at 15,352 common shares held directly. In addition, he reports 1,300 shares held through the McLaughlin Revocable Trust and 524 shares held by the McLaughlin 2020 Dynasty LLC, for which he is trustee/manager, bringing total reported holdings to 17,176 shares. No shares were sold or disposed of.

The filing represents routine director compensation and signals continued alignment with shareholder interests; however, the size of the grant is not material relative to Snowflake鈥檚 outstanding share count and is unlikely to affect the company鈥檚 valuation.

Snowflake Inc. (SNOW) 鈥� Form 4 insider filing dated 07/03/2025

Director Kelly A. Kramer reported the award of 1,373 restricted stock units (RSUs) on 07/02/2025. The grant carries no cash consideration (reported price $0) and will vest in full on the earlier of (i) the 2026 annual shareholder meeting (or immediately prior if the director leaves the board at that meeting) or (ii) the first anniversary of the grant date, contingent on continued board service. After this transaction, Kramer鈥檚 direct beneficial ownership rises to 8,801 common shares, which includes shares that will be issued upon future RSU vesting. No derivative securities or sales were reported.

The filing reflects standard director compensation and does not indicate open-market buying or selling.

Snowflake Inc. (SNOW) 鈥� Form 4 insider filing

Director Mark Garrett reported the award of 1,373 restricted stock units (RSUs) on 07/02/2025. The RSUs carry a grant price of $0 and will vest in full on the earlier of the company鈥檚 2026 annual shareholder meeting or the first anniversary of the grant date, contingent on continued board service.

Following the grant, Garrett now holds 8,801 common shares directly and 121,010 shares indirectly through four family trusts, bringing his aggregate beneficial ownership to 129,811 shares.

No derivative transactions, sales, or open-market purchases were reported. The filing reflects routine director compensation designed to align board incentives with shareholder interests; it does not signal a change in company fundamentals.

SRM Entertainment, Inc. (SRM) 鈥� Form 4 filing dated 07/03/2025

Chief Financial Officer Douglas O. McKinnon reported a series of open-market sales executed on 07/01/2025 after exercising stock options granted under the 2024 Equity Incentive Plan. Five separate transactions were disclosed, totaling 122,000 common shares sold at prices ranging from $6.63 to $7.65 per share, producing an estimated weighted-average sale price of roughly $7.39.

Prior to the first sale, the CFO beneficially owned about 438,388 shares. Following the final transaction, his direct ownership declined to 316,388 shares, a reduction of roughly 28% of his previous position. No derivative positions were reported after the transactions, and no additional option exercises were listed beyond those already converted to shares and sold.

The filing contains no information on company operations, financial performance, or future plans. However, insider sales鈥攑articularly by a senior financial executive鈥攃an be interpreted by investors as a potential negative sentiment signal. It is unclear whether the sales were made under a pre-arranged 10b5-1 trading plan; the box is not marked, and the explanation notes only that the shares originated from option exercises.

While McKinnon retains a significant equity stake, the scale and single-day timing of the disposals may draw attention from shareholders monitoring insider activity for insight into management鈥檚 outlook.

Form 4 Overview 鈥� Inozyme Pharma, Inc. (INZY)

This Form 4 discloses that Robert L. Hopfner, a director of Inozyme Pharma and managing partner of Pivotal bioVenture Partners, disposed of his indirect holdings in the company on 1 July 2025 as a result of Inozyme鈥檚 acquisition by BioMarin Pharmaceutical Inc.

• Transaction structure: The shares were tendered pursuant to the Agreement and Plan of Merger dated 16 May 2025 between Inozyme, BioMarin and Incline Merger Sub.
• Consideration: All common shares were exchanged for $4.00 cash per share (the 鈥淢erger Consideration鈥�), without interest and subject to tax withholding.
• Holdings affected:
  • Pivotal bioVenture Partners Fund I, L.P. 鈥� 2,923,110 shares
  • Pivotal bioVenture Partners Fund II, L.P. 鈥� 1,571,741 shares
  Total indirect disposition: 4,494,851 shares.
• Post-merger status: Effective 1 July 2025, Incline Merger Sub merged with and into Inozyme, making Inozyme a wholly-owned subsidiary of BioMarin.

No derivative securities were reported. The filing is made by one reporting person and executed by power of attorney.

Redwire Corporation (RDW) filed a Form 4 reporting that Chairman & CEO Peter A. Cannito disposed of 12,779 common shares on 01 Jul 2025 under transaction code 鈥淔鈥�, which denotes shares withheld by the company to cover payroll taxes triggered by the vesting of restricted stock units (RSUs). The withholding price was the closing price of $15.31 on the vesting date. Following the mandatory tax-related surrender, Cannito鈥檚 direct ownership stands at 455,095 RDW shares, including 7,544 shares accumulated through the employee stock purchase plan. No open-market sale or cash proceeds were involved; the event is an administrative adjustment related to equity compensation and does not change the executive鈥檚 net exposure to the stock.

Snowflake Inc. (SNOW) 鈥� Form 144 filing dated 07/03/2025

The filing discloses that Frank Slootman intends to sell 178,949 Class A shares, representing roughly 0.054 % of Snowflake鈥檚 333.7 million shares outstanding. Based on the reported market price, the proposed sale is valued at $39.6 million. Fidelity Brokerage Services LLC is listed as the executing broker and the shares will be sold on the NYSE.

Recent insider activity

• During the previous three weeks (06/10/2025-07/02/2025), Slootman sold 1,439,879 Class A shares for gross proceeds of $316.5 million.
• The additional 178,949 shares would lift the cumulative three-month total to roughly 1.62 million shares, or 0.49 % of current shares outstanding.

The sales stem from option grants dated 05/29/2019 and appear to be cash-settled. The form contains the customary representation that the filer is unaware of undisclosed material information.

Investment view: While the percentage of total outstanding shares is small, the magnitude and frequency of recent insider sales鈥攑articularly by the company鈥檚 chief executive鈥攎ay weigh on investor sentiment and create short-term technical pressure on SNOW鈥檚 share price.

Snowflake Inc. (SNOW) 鈥� Form 4 insider transaction

President of Products and Director Benoit Dageville reported an option exercise and coincident share sale on 06/30/2025:

• Option exercise (Code M): 25,000 Class A shares acquired at an exercise price of $0.74, costing roughly $18.5 k.
• Open-market sale (Code S): 25,000 Class A shares sold at an average price of $224.84, generating about $5.6 m gross proceeds.
• Direct ownership decreased to 58,325 shares from 83,325 after the paired transactions.
• The option exercised was fully vested and expires 02/07/2027; 419,863 options remain outstanding.

The trades were executed under a 10b5-1 trading plan adopted on 03/28/2025, providing pre-arranged execution and reducing the likelihood of information-based timing concerns.

Dageville continues to have large indirect stakes held in several trusts鈥攖wo GRATs of 750,000 shares each and the Snow Trust holding 3,191,555 shares鈥攁lthough he disclaims beneficial ownership of one GRAT.

While the $5.6 m sale is relatively small versus total indirect holdings (~4.7 m shares) and was plan-driven, it trims direct exposure by roughly 30% and can be interpreted by some investors as modestly negative insider sentiment. No company-level financials or operational updates are contained in this filing.